Nephros Inc: Form 10-Q for the period ended Jun 30, 2013
Filed with the SEC on Aug 13, 2013 and accepted by EDGAR at Aug 13, 2013, 16:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-04-01 to 2013-06-30 | $575.0k | us-gaap:SalesRevenueNet |
| Revenue | 6 months2013-01-01 to 2013-06-30 | $1.1m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2013-04-01 to 2013-06-30 | $226.0k | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2013-01-01 to 2013-06-30 | $421.0k | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2013-04-01 to 2013-06-30 | $349.0k | us-gaap:GrossProfit |
| Gross profit | 6 months2013-01-01 to 2013-06-30 | $675.0k | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2013-04-01 to 2013-06-30 | $660.0k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2013-01-01 to 2013-06-30 | $1.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2013-04-01 to 2013-06-30 | −$628.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2013-01-01 to 2013-06-30 | −$1.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2013-04-01 to 2013-06-30 | $24.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2013-01-01 to 2013-06-30 | $47.0k | us-gaap:InterestExpense |
| Net income | 3 months2013-04-01 to 2013-06-30 | −$671.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months2013-01-01 to 2013-06-30 | −$1.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-04-01 to 2013-06-30 | −$0.05 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2013-01-01 to 2013-06-30 | −$2.8m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Cash and equivalents | At period end2013-06-30 | $298.0k | us-gaap:Cash |
| Current assets | At period end2013-06-30 | $870.0k | us-gaap:AssetsCurrent |
| Total assets | At period end2013-06-30 | $2.9m | us-gaap:Assets |
| Current liabilities | At period end2013-06-30 | $1.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-06-30 | $2.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2013-06-30 | $841.0k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-13-045172. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.